drugset / Trial / NCT06942377
Calcium Channel Blocker Amlodipine for Endometrial Cancer Therapy
RandomizedParallel-groupOpen-labelTreatment
Summary
To explore the treatment efficacy of Progesterone Therapeutic Regimen Plus Amlodipine in patients with early endometrial carcinoma (EEC) for conservative treatment.
Timeline
- Start
- 2025-07-15
- Primary completion
- 2027-01-01
- Completion
- 2027-12-01
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Amlodipine | Other / unclassified | 5 mg | Oral |
| Subject | Amlodipine | Other / unclassified | 10 mg | Oral |